Company intelligence / Profile preview

MSD

Ownership: Private
Employees: ~75000
Development stage: Commercial

Overview

MSD/Merck has a robust commercial portfolio with blockbuster drugs such as Keytruda for oncology and Gardasil for HPV prevention. The company continues to advance new medicines through all phases of clinical development across oncology, vaccines, infectious diseases, cardiometabolic disorders and more. Its immuno-oncology program led by Keytruda has shown significant survival benefits in several cancers.[2][8] The company also maintains a strong presence in animal health.[3]

Therapeutic areas: OtherOncologyEndocrinologyInfectious Diseases
Modalities: Small moleculesMonoclonal antibodies (mAbs)Vaccines/biologics
Industry: Pharma

Partnerships

Includes collaborations with academic institutions globally,[9] partnerships for COVID vaccines/drugs development,[9] alliances with biotech firms for co-development/licensing.

Beyond the preview

Go deeper on MSD.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MSD.

Explore the full profile